Clinical Trial Update: A Study of HB0045 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update for HB0045 Injection in adults with solid tumors is ongoing, with current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• HB0045 Injection

Snippet

Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. | Conditions: Solid Tumor, Adult | Phase 1, Phase 2 | Status: UNKNOWN